ABSORPTION KINETICS - PowerPoint PPT Presentation

About This Presentation
Title:

ABSORPTION KINETICS

Description:

CHAPTER 7 ABSORPTION KINETICS ABSORPTION GIT ABSORPTION FROM GIT Oral Dosage Forms Advantages of Oral Drugs Convenient, portable, no pain Easy to take Cheap, no need ... – PowerPoint PPT presentation

Number of Views:1428
Avg rating:3.0/5.0
Slides: 42
Provided by: pharmacy41
Category:

less

Transcript and Presenter's Notes

Title: ABSORPTION KINETICS


1
CHAPTER 7
  • ABSORPTION KINETICS

2
ABSORPTION
  • GIT

3
ABSORPTION FROM GIT
  • Oral Dosage Forms

4
Advantages of Oral Drugs
  • Convenient, portable, no pain
  • Easy to take
  • Cheap, no need for sterilization
  • Compact, multi-dose bottles
  • Automated machines producing
  • tablets in large quantities
  • Variety- fast release, enteric coated,
  • capsules, slow release, ..

5
ABSORPTION
  • Definition is the net transfer
  • of drug from the site of
  • absorption into the circulating
  • fluids of the body.
  • For Oral Absorption
  • 1- Cross the epithelium of the GIT and entering
    the blood via capillaries
  • 2- Passing through the hepato-portal system
    intact into the systemic circulation

6
ABSORPTION
7
Biological Membranes
No matter by which route a drug is administered
it must pass through several to many biological
membranes during the process of absorption,
distribution, biotransformation and elimination.
8
Cell Membrane Structure
It is a bimolecular layer of lipid material
entrained between two parallel monomolecular
layers of proteins.
9
Cell Membrane Structure
The cell membrane appears to be perforated by
water-filled pores of various sizes, varying from
about 4 to 10 A
10
Drug Transport
Transport is the movement of drug from one place
to another within the body. Most drugs pass
through membranes by diffusion. The process is
passive because no external energy is expended.
PARACELLULAR
TRANSCELLULAR
11
PASSIVE DIFFUSION
  • The passage of drug
  • molecules occurring from
  • the side of high drug
  • concentration to low drug
  • concentration

12
Ficks law of diffusion
  • Q is the net quantity of drug transferred
    across the membrane, t is the time
  • Ch is the conc on one side (GIT) and Cl that
    on the other side (plasma)
  • x is the thickness of the membrane
  • A is surface area of membrane and D is the
    diffusion coefficient related to permeability
  • k is the partition coefficient of the drug

13
SMALL INTESTINE VILLI
14
PERMEABILITY
  • The permeability of a membrane to a drug depends
  • on physico-chemical properties of drugs
  • Lipophilicity membranes are highly permeable to
    lipid
  • soluble drugs
  • Molecular size important in paracellular route
    and in
  • drugs bound to plasma protein. Macromolecules
    such
  • as proteins do not traverse cell membrane or do
    so
  • very poorly
  • Charge cell membranes are more permeable to
  • unionized forms of drugs because of more lipid
  • solubility

15
PERMEABILITY
16
Carrier-Mediated Transport
  • Active Transport
  • The drug is transported against a concentration
    gradient .This
  • system is an ENERGY consuming system.
  • Example Glucose and Amino acids transport.

17
Passive Facilitated Diffusion
  • A drug carrier is
  • Required but no ENERGY
  • is necessary. e.g. vitamin
  • B12 transport. Drug
  • moves along conc
  • gradient (from high to
  • low), downhill but faster

DRUG
CARRIER
18
DRUG TRANSPORT
19
Characteristics of GIT
20
Effect of Food on Drug Absorption
  • Propranolol

21
Effect of Diseases on Drug Absorption
  • Diseases that cause changes in
  • Intestinal blood flow
  • GI motility
  • Stomach emptying time
  • Gastric and intestinal pH
  • Permeability of the gut wall
  • Bile and digestive enzyme secretion
  • Alteration of normal GI flora

22
Simulation of Drug Absorption by Dissolution
Methods
  • Dissolution tests in vitro measure the rate and
    extent of dissolution of the drug from a dosage
    form in an aqueous medium

23
ABSORPTION KINETICS
  • Plasma Concentration-Time Curve

Tmax
24
First-Order Absorption
25
Absorption
  • Zero-Order Absorption is seen with controlled
  • release dosage forms as well as with poorly
    soluble
  • drugs. The rate of input is constant.
  • First-Order Absorption is seen with the majority
    of
  • extravascular administration (oral, IM, SC,
    rectal,
  • ect..) Most PK models assume first-order
    absorption
  • unless otherwise stated.

26
One Compartment Model for First-Order Absorption
and First-Order Elimination
  • Gastrointestinal, Percutaneous, Subcutaneous,
  • Intramuscular, Ocular, Nasal, Pulmonary,
    Sublingual,

Drug in dosage form
Release
Drug particles In body fluid
Dissolution
Central Compartment (Plasma)
ka
kel
Drug in solution
Elimination
Absorption
27
COMPARTMENTAL MODEL
  • One compartment model with Extravascular
  • administration

Route of Administration Oral, IM, SC, Rectal,
ect
28
First-Order Absorption Model
  • Rate of change rate of input rate of output
  • Integrated Equation

29
The Residual Method
  • The rising phase is not log-linear because
    absorption
  • and elimination are occurring simultaneously

30
The Residual Method
31
The Residual Method
32
The Residual Method
33
Cmax and tmax
  • The time needed to reach Cmax is tmax

At the Cmax the rate of drug absorbed is equal to
the rate of drug eliminated
34
Lag Time
  • The time delay prior to the commencement of
  • first-order drug absorption is known as lag time

Cp
Lag time
Time
35
FLIP-FLOP of ka and kel
  • In a few cases, the kel obtained from oral
  • absorption data does not agree with that
  • obtained after i.v. bolus injection. For
  • example, the kel calculated after i.v. bolus
  • injection of a drug was 1.72 hr -1, whereas
  • the kel calculated after oral administration
  • was 0.7 hr -1. When ka was obtained by the
  • method of residuals, the rather surprising
  • result was that the ka was 1.72 hr -1

36
FLIP-FLOP of ka and kel
  • Drugs observed to have flip-flop characteristics
    are drugs with fast elimination (kel gt ka)
  • The chance for flip-flop of ka and kel is greater
    for drugs that have a kel gt 0.69 hr-1
  • The flip-flop problem also often arises when
    evaluating controlled-release products
  • The only way to be certain of the estimates is to
    compare the kel calculated after oral
    administration with the kel from intravenous data.

37
FLIP-FLOP of ka and kel
38
Effect of size of the dose of a drug on the peak
concentration and time of peak concentration
  • The time of peak conc is the same for all doses

A gtB gtC
39
Effect of altering ka on Cmax and Tmax
  • The faster the absorption the higher is the Cmax
    and the
  • shorter is the Tmax

40
Effect of altering kel on Cmax and Tmax
  • The faster the elimination the lower is the Cmax
    and the
  • shorter is the Tmax

41
Equations


Write a Comment
User Comments (0)
About PowerShow.com